glp-1 stomach acid drugs increase risk of reflux, GERD, study finds Frontiers | GLP−1 receptor agonists
Description
A.VacaroiuI
Microdosing does not independently protect muscle
For Cross Cutting Issue No
All patients improved but the results were more profound for Stage 2 patients b
Clinical trials have found that most side effects improve with time
It's whether psychiatrists will lead that shift or be caught flat-footed by it
